Terumo Corporation · TSE:4543

Terumo — Investor Presentation (November 2013)

9 slides from Terumo's investor presentation, Nov 6, 2013

  1. Slide 1: Progress on The Mid-term Plan New Approach for Innovation

    Progress on The Mid-term Plan New Approach for Innovation Terumo Corporation President & Representative Director Yutaro Shintaku November 6, 2013

  2. Slide 2: Mid-term Forecast by Segment

    Mid-term Forecast by Segment 25% Cardiac & Vascular Blood Management 20% Sales Growth (FY12-16) OP Margin % OP Margin% (FY16) General Hospital Sales Growth (FY08-12) OP Margin% (FY12) 15% 10% 0% 5% 10% 15% Sales Growth (CAGR) (Note) Without FX impact, OP Margin% before D&A 2013/11/6 ©Terumo Corporat

  3. Slide 3: Highlights of Each Business

    Highlights of Each Business  Cardiac & Vascular: sustained strong performance even under severe business environment  Launched new products pipeline on time  Promoted “selection and focus” of R&D project (sold DH-II asset)  Achieved steady progress on the improvement of quality management system

  4. Slide 4: Blood Management Business

    Blood Management Business  Changes in business environment mainly in EU and US (Unit of bags) US Red Blood Cell Issues (Unit of bags) US Platelet Issues 750,000 150,000 700,000 650,000 130,000 600,000 110,000 550,000 500,000 90,000 450,000 400,000 70,000 350,000 300,000 50,000 2010 2011 2012 2013 2

  5. Slide 5: Blood Management Business: Steady Growth in 1H

    Blood Management Business: Steady Growth in 1H  Developed market: growth driven by high value added products  Improve output and efficiency of works at blood centers with automated blood processing system  Expand in application of therapeutic apheresis system  Emerging market: mark double digit

  6. Slide 6: Step into The Core of Silicon Valley

    Step into The Core of Silicon Valley  Participate in incubation program  NPO for incubation, located on the campus of El Camino Hospital  Develop therapeutic devices for new field, Urology  Plan to have more than ten engineers reside  Invest in venture capital fund  Invest up to 2.5 BJPY, the

  7. Slide 7: Dr. Fogarty: One of Great Person in PCI History

    Dr. Fogarty: One of Great Person in PCI History Seldinger Sones Fogarty Dotter Balloon JL, JR AL, AR PTCA Technique Technique Catheter Technique Catheter Fixed Wire Coronary Balloon Catheterization 1956 Nobel Prize in Medicine <Reference> 1978 New Device Report The US first PTCA case by Dr. Fumiaki

  8. Slide 8: Message from Dr. Fogarty

    Message from Dr. Fogarty 2013/11/6 ©Terumo Corporation 8/9

  9. Slide 9: IR Contact

    IR Contact Terumo Corporation Corporate Communication (IR) Dept. E-mail: [email protected] Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not i

Terumo — Investor Presentation (November 2013) on 6ix